• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原激活物抑制剂-1(PAI-1)-675 4G/5G多态性与不明原因女性不孕症的关联。

Association of plasminogen activator inhibitor-type 1 (PAI-1) -675 4G/5G polymorphism with unexplained female infertility.

作者信息

Kydonopoulou K, Delkos D, Rousso D, Ilonidis G, Mandala E

机构信息

Fourth Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece.

Third Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece.

出版信息

Hippokratia. 2017 Oct-Dec;21(4):180-185.

PMID:30944508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6441347/
Abstract

BACKGROUND

Infertility is a major issue of concern for couples at reproductive age.  The underlying causes of infertility remain unknown in 15-30 % of the cases. Plasminogen activator inhibitor type 1 (PAI-1), which is a major fibrinolytic factor, has been associated with increased infertility risk.  DNA variants at such as -675 4G/5G promoter polymorphism, have been implicated in infertility-related reproductive disorders, possibly due to a molecular mechanism involving implantation failure. This study aims to investigate the association of 4G/5G polymorphism to otherwise unexplained female infertility in a sample of women of Greek ethnic origins.

METHODS

We enrolled in this study 222 women from the population of Northern Greece; 115 women with unexplained infertility (group 1) and 107 normal fertile women (group 2). All participants were genotyped for -675 by real-time polymerase chain reaction.

RESULTS

Our results indicate an association with the 4G allele in our sample of women with unexplained infertility. The dominant genetic model supports the association, in contrast to the recessive genetic model.

CONCLUSIONS

Our results indicate that 4G/5G polymorphism is a promising screening factor which could potentially be a target for certain cases of unexplained female infertility. However, they should be interpreted with caution and should be validated in larger studies and diverse populations. In addition, other variants in genes involved in thrombophilia might need to be considered. HIPPOKRATIA 2017, 21(4): 180-185.

摘要

背景

不孕症是育龄夫妇关注的主要问题。15%-30%的不孕症病例病因不明。纤溶酶原激活物抑制剂1型(PAI-1)是一种主要的纤溶因子,与不孕症风险增加有关。诸如-675 4G/5G启动子多态性等DNA变异与不孕症相关的生殖障碍有关,可能是由于涉及植入失败的分子机制。本研究旨在调查希腊族裔女性样本中4G/5G多态性与不明原因女性不孕症之间的关联。

方法

我们招募了来自希腊北部的222名女性参与本研究;115名不明原因不孕症女性(第1组)和107名正常可育女性(第2组)。通过实时聚合酶链反应对所有参与者进行-675基因分型。

结果

我们的结果表明,在不明原因不孕症女性样本中,4G等位基因存在关联。与隐性遗传模型相比,显性遗传模型支持这种关联。

结论

我们的结果表明,4G/5G多态性是一个有前景的筛查因素,可能是某些不明原因女性不孕症病例的潜在靶点。然而,这些结果应谨慎解释,并应在更大规模的研究和不同人群中进行验证。此外,可能需要考虑血栓形成倾向相关基因的其他变异。《希波克拉底》2017年,21(4): 180 - 185。

相似文献

1
Association of plasminogen activator inhibitor-type 1 (PAI-1) -675 4G/5G polymorphism with unexplained female infertility.纤溶酶原激活物抑制剂-1(PAI-1)-675 4G/5G多态性与不明原因女性不孕症的关联。
Hippokratia. 2017 Oct-Dec;21(4):180-185.
2
Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.纤溶酶原激活物抑制剂 1 4G/5G 和-844G/A 变体与特发性复发性妊娠丢失的关系。
Am J Reprod Immunol. 2013 Sep;70(3):246-52. doi: 10.1111/aji.12116. Epub 2013 Mar 22.
3
Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis.纤溶酶原激活物抑制剂-1(PAI-1)4G/5G 多态性与阿尔茨海默病、代谢综合征和女性不孕风险的关联:一项荟萃分析。
Medicine (Baltimore). 2020 Dec 11;99(50):e23660. doi: 10.1097/MD.0000000000023660.
4
4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.深静脉血栓形成患者PAI-1基因启动子4G/5G多态性与纤溶能力
Thromb Haemost. 1998 Dec;80(6):956-60.
5
Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.心肌梗死中纤溶酶原激活物抑制因子-1(PAI-1)4G/5G和-844G/A基因多态性与PAI-1/组织纤溶酶原激活物水平变化的关联:一项病例对照研究
Genet Test Mol Biomarkers. 2010 Feb;14(1):23-7. doi: 10.1089/gtmb.2009.0039.
6
Association of the plasminogen activator inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G promoter polymorphism with risk of keloid in a Chinese Han population.纤溶酶原激活物抑制剂-1(PAI-1)基因-675 4G/5G和-844 A/G启动子多态性与中国汉族人群瘢痕疙瘩风险的相关性
Med Sci Monit. 2014 Oct 28;20:2069-73. doi: 10.12659/MSM.892397.
7
Plasminogen Activator Inhibitor-1 4G/5G Promoter Polymorphism in Indian Patients with Deep Vein Thrombosis.印度深静脉血栓形成患者中纤溶酶原激活物抑制剂-1 4G/5G启动子多态性
Indian J Hematol Blood Transfus. 2024 Apr;40(2):331-334. doi: 10.1007/s12288-023-01660-3. Epub 2023 May 8.
8
Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.健康日本男性中纤溶酶原激活物抑制剂-1(PAI-1)4G/5G多态性的基因型频率及其与PAI-1水平的关系。
Int J Hematol. 1999 Jan;69(1):43-7.
9
Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.纤溶酶原激活物抑制剂-1(PAI-1)4G/5G启动子多态性与静脉血栓栓塞风险——一项荟萃分析与系统评价
Vasa. 2020 Mar;49(2):141-146. doi: 10.1024/0301-1526/a000839. Epub 2020 Jan 10.
10
Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.乳腺癌患者纤溶酶原激活物抑制剂-1 4G/5G多态性及其与组织纤溶酶原激活物抑制剂-1水平和肿瘤严重程度的关联。
Thromb Res. 2006;117(5):487-92. doi: 10.1016/j.thromres.2005.03.025.

引用本文的文献

1
Evaluation of Risk Factors and a Gene Panel as a Tool for Unexplained Infertility Diagnosis by Next-Generation Sequencing.评估风险因素及基因检测板作为通过下一代测序诊断不明原因不孕症的工具
Medicina (Kaunas). 2025 Feb 5;61(2):271. doi: 10.3390/medicina61020271.
2
Evidence-based guideline: unexplained infertility†.基于证据的指南:不明原因不孕†。
Hum Reprod. 2023 Oct 3;38(10):1881-1890. doi: 10.1093/humrep/dead150.
3
DNA Methylation of Window of Implantation Genes in Cervical Secretions Predicts Ongoing Pregnancy in Infertility Treatment.宫颈分泌物着床窗基因的 DNA 甲基化预测不孕治疗中的持续妊娠。
Int J Mol Sci. 2023 Mar 15;24(6):5598. doi: 10.3390/ijms24065598.
4
Involvement of single nucleotide polymorphisms in ovarian poor response.单核苷酸多态性与卵巢低反应的关系。
J Assist Reprod Genet. 2021 Sep;38(9):2405-2413. doi: 10.1007/s10815-021-02242-w. Epub 2021 May 29.
5
Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis.纤溶酶原激活物抑制剂-1(PAI-1)4G/5G 多态性与阿尔茨海默病、代谢综合征和女性不孕风险的关联:一项荟萃分析。
Medicine (Baltimore). 2020 Dec 11;99(50):e23660. doi: 10.1097/MD.0000000000023660.
6
Interaction of thrombophilic SNPs in patients with unexplained infertility-multifactor dimensionality reduction (MDR) model analysis.不明原因不孕患者血栓形成倾向 SNP 的相互作用-多因子降维(MDR)模型分析。
J Assist Reprod Genet. 2020 Jun;37(6):1449-1458. doi: 10.1007/s10815-020-01808-4. Epub 2020 May 13.
7
Molecular basis of senescence transmitting in the population of human endometrial stromal cells.人子宫内膜基质细胞群体中衰老传递的分子基础。
Aging (Albany NY). 2019 Nov 5;11(21):9912-9931. doi: 10.18632/aging.102441.

本文引用的文献

1
Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases.1型纤溶酶原激活物抑制剂在女性生殖系统疾病病理中的作用
Int J Mol Sci. 2017 Jul 29;18(8):1651. doi: 10.3390/ijms18081651.
2
Intrauterine trophoblast migration: A comparative view of humans and rodents.子宫内滋养层细胞迁移:人类与啮齿动物的比较观察
Cell Adh Migr. 2016 Mar 3;10(1-2):88-110. doi: 10.1080/19336918.2015.1120397. Epub 2016 Jan 8.
3
Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.纤溶酶原激活物抑制剂-1 4G/5G多态性与复发性流产关联的Meta分析
Med Sci Monit. 2015 Apr 11;21:1051-6. doi: 10.12659/MSM.892898.
4
uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies.尿激酶型纤溶酶原激活剂(uPA)和纤溶酶原激活剂抑制剂-1(PAI-1)作为乳腺癌生物标志物:在证据水平为1的研究中已验证可用于临床。
Breast Cancer Res. 2014 Aug 22;16(4):428. doi: 10.1186/s13058-014-0428-4.
5
Functional stability of plasminogen activator inhibitor-1.纤溶酶原激活物抑制剂-1的功能稳定性
ScientificWorldJournal. 2014;2014:858293. doi: 10.1155/2014/858293. Epub 2014 Oct 15.
6
Association between plasminogen activator inhibitor-1 gene polymorphisms and recurrent pregnancy loss: a systematic review and meta-analysis.纤溶酶原激活物抑制剂-1基因多态性与复发性流产的关联:一项系统评价和荟萃分析。
Am J Reprod Immunol. 2015 Apr;73(4):292-300. doi: 10.1111/aji.12321. Epub 2014 Sep 24.
7
Adaptive mechanisms controlling uterine spiral artery remodeling during the establishment of pregnancy.妊娠建立过程中控制子宫螺旋动脉重塑的适应性机制。
Int J Dev Biol. 2014;58(2-4):247-59. doi: 10.1387/ijdb.140083ms.
8
Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome.药物治疗对多囊卵巢综合征妇女血浆纤溶酶原激活物抑制剂-1水平的不同影响。
Hormones (Athens). 2013 Oct-Dec;12(4):559-66. doi: 10.14310/horm.2002.1444.
9
Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.纤溶酶原激活物抑制剂-1 4G/5G与亚甲基四氢叶酸还原酶677C/T基因多态性及多囊卵巢综合征易感性:一项荟萃分析
Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:8-14. doi: 10.1016/j.ejogrb.2013.12.030. Epub 2014 Jan 3.
10
Association between plasminogen activator inhibitor 1 gene mutation and different subgroups of recurrent miscarriage and implantation failure.纤溶酶原激活物抑制剂 1 基因突变与不同亚组复发性流产和着床失败的关系。
J Assist Reprod Genet. 2014 Jan;31(1):121-4. doi: 10.1007/s10815-013-0125-8. Epub 2013 Nov 6.